Molina Healthcare price target lowered to $356 from $406 at Cantor Fitzgerald

Cantor Fitzgerald lowered the firm’s price target on Molina Healthcare (MOH) to $356 from $406 and keeps an Overweight rating on the shares. Though sentiment is leaning negative on some assumptions, Cantor believes conservatism is already baked into guidance and believes the stock decline is a “harsh” reaction to the guidance, the analyst tells investors in a research note. Some of the selloff is likely tied to uncertainty around the Trump administration’s plans for Medicaid, but mostly lack of confidence in Molina’s bullish 2025 Medicaid medical loss ratio guidance that puts them only 100 basis points off the long-term guidance range. The firm views the stock as inexpensive here and sees 2025 guidance as achievable.